EUVIMEDEUVIMED entdecken
Crossref

15P Capivasertib plus fulvestrant in PIK3CA/AKT/PTEN-altered HR+/HER2- advanced breast cancer: A multicentre real-world study

M.V. Bonomo, S. Scagnoli, F. Pantano, R. Scafetta, P. Vici, A. Astone, V. Rossi, I. Paris, A. Orlandi, A. Fabi, E. Giordani, M.A. Fabbri und 8 weitere

Annals of Oncology · 2026-12 · 37 · S380

DOI: 10.1016/j.annonc.2026.08.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Oncology, 2026-12. Verfasst von M.V. Bonomo und 19 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bonomo, M., Scagnoli, S., Pantano, F., Scafetta, R., Vici, P., Astone, A., Rossi, V., Paris, I., Orlandi, A., Fabi, A., Giordani, E., Fabbri, M., D'Auria, G., Pisegna, S., Alesini, D., Falbo, P., Bonadonna, C., Verrico, M., Bria, E., & Botticelli, A. (2026). 15P Capivasertib plus fulvestrant in PIK3CA/AKT/PTEN-altered HR+/HER2- advanced breast cancer: A multicentre real-world study. Annals of Oncology, 37, S380. https://doi.org/10.1016/j.annonc.2026.08.024

Vancouver

Bonomo M, Scagnoli S, Pantano F, Scafetta R, Vici P, Astone A, et al. 15P Capivasertib plus fulvestrant in PIK3CA/AKT/PTEN-altered HR+/HER2- advanced breast cancer: A multicentre real-world study. Annals of Oncology. 2026;37:S380. doi:10.1016/j.annonc.2026.08.024

BibTeX
@article{Bonomo2026,
  author = {Bonomo, M.V. and Scagnoli, S. and Pantano, F. and Scafetta, R. and Vici, P. and Astone, A. and Rossi, V. and Paris, I. and Orlandi, A. and Fabi, A. and Giordani, E. and Fabbri, M.A. and D'Auria, G.D. and Pisegna, S. and Alesini, D. and Falbo, P.T. and Bonadonna, C. and Verrico, M. and Bria, E. and Botticelli, A.},
  title = {15P Capivasertib plus fulvestrant in PIK3CA/AKT/PTEN-altered HR+/HER2- advanced breast cancer: A multicentre real-world study},
  journal = {Annals of Oncology},
  year = {2026},
  volume = {37},
  pages = {S380},
  doi = {10.1016/j.annonc.2026.08.024}
}
Kostenlos starten →